Gene Query: MRPL47

Dataset Description Geneva Score
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 24.84
Unique features and clinical importance of acute alloreactive immune responses 24.82
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 21.67
Systematic discovery of endogenous human ribonucleoprotein complexes 20.97
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 20.53
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 16.38
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 16.2
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 16.13
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 15.66
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 15.29
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 14.7
Hijacking of stress response machinery by oncogenes in acute leukaemia 14.7
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 14.42
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 14.21
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 13.71
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 13.71
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 13.3
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 13.03
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 12.69
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.49
Regulation of protein translation during mitosis 12.45
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 12.43
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 12.37
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 12.31
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 12.31
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 12.12
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 11.95
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 11.94
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.78
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 11.61
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.57
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 11.48
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 11.34
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 11.34
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.33
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 11.08
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.42
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.42
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.28
Generating Patterned Kidney Organoids for Studying Development and Diseases 10.25
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.23
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.99
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.88
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 9.7
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 9.51
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 9.51
Global analysis of enhancer targets: Mosaic-seq 9.5
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 9.48
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 9.23
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 9.05
Iron response of HepG2 cells 8.95
Transcriptome sequencing of K-562 cells 8.78
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 8.75
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.72
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 8.67
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.66
CROP-Seq in Primary Human T Cells 8.57
RNA expression following TMPRSS11B overexpression or depletion 8.39
HEK293 TFAM Knockout Expression Study 8.38
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 8.32
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 8.25
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 8.22
Cleavage Factor Im as a key regulator of 3’ UTR length 8.22
mRNA expression profile of Lymphocytes 8.21
Transcriptome analysis of U87 cells upon LINC00152 knockdown 8.21
Altering cancer transcriptomes using epigenomic inhibitors 8.2
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 8.2
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 8.0
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.93
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 7.9
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 7.87
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 7.75
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.57
CD73 knockdown effect in pancreatic cancer cell lines 7.55
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 7.55
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 7.5
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.49
SRSF2 mutations impair hematopoiesis and alter exon recognition 7.43
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.41
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 7.41
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 7.39
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.33
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.33
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 7.33
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 7.33
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.28
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.19
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.14
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 7.07
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.05
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.03
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.94
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.94
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.94
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.94
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.92
Accurate annotation of human protein-coding small open reading frames 6.91
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.77
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.77
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.76
ETV7 and interferon response 6.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.75
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.7
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.7
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.69
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.69
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.69
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.68
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 6.68
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.65
Global expression profiles in cardiac progenitor cells generated by ISX-9 6.64
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 6.64
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.58
T47D RNA-seq and ChrRNA-seq data 6.58
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.58
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.58
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 6.54
Transcriptomic analyssis following EHMT1/2 inhibition 6.53
Lysine benzoylation is a novel histone mark [RNA-seq] 6.52
Lysine benzoylation is a novel histone mark 6.52
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.47
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 6.41
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.35
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.33
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.3
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 6.27
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 6.27
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 6.26
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 6.26
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 6.26
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 6.21
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.21
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 6.16
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.14
FOXD3 is a novel tumor suppressor in lung cancer 6.1
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.01
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.0
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.0
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 5.98
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 5.98
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 5.96
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.96
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.93
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.9
The landscape of alternative splicing in aggressive prostate cancers 5.88
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.81
RNA editing in nascent RNA affects pre-mRNA splicing 5.79
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.78
Identification of renal resident macrophages across species 5.76
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.74
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 5.74
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 5.74
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.67
RNA-sequencing of healthy human skeletal myocytes 5.64
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 5.63
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.57
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.45
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.42
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 5.36
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 5.36
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.33
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.33
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.32
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.31
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.31
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.29
Seletive inhibition of CDK9 in DLBCL cell lines 5.27
A prostate cancer chromatin interaction map 5.27
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.25
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 5.22
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.22
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.17
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.16
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.16
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.13
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.12
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.1
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 5.1
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.06
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.02
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.02
The regulartory role of ZCCHC24 in splicing machinery 5.01
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.0
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.97
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 4.96
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 4.96
Human embryonic stem cells in E8 and AKIT culture medium 4.94
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.94
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 4.94
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 4.94
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.94
Effect of ILF3 on translation during homeostasis and the antiviral response 4.93
Trans-differentiation of human adult peripheral blood T cells into neurons 4.92
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.9
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.9
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.89
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 4.88
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 4.87
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.86
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.86
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.83
Illumina Total RNA-seq in HeLa 4.81
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 4.8
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.8
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.79
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 4.78
MOF acetyl transferase regulates transcription and respiration in mitochondria 4.74
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.73
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.72
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 4.7
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 4.7
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.69
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.69
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.68
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.67
Landscape and variation of RNA secondary structure across the human transcriptome 4.66
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.65
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.65
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 4.64
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.63
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.63
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 4.6
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.6
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.59
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.57
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.52
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 4.52
RNA-Seq with and without RNase treatment in PCa cell lines 4.51
Effect of PBK knockdown on C4-2 cell transcriptome 4.5
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.46
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.46
The cohesin complex prevents Myc-induced replication stress 4.44
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 4.43
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 4.42
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.36
SLAM-seq for K562 endogenous mRNA decay 4.29
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.26
Analysis of transcriptional regulation by Myt1 and Myt1l 4.25
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.23
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.21
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.2
The comparison of high-throughput single-cell RNA-seq methods 4.18
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.18
RNA sequencing of matched nephrectomy samples [RNA-seq] 4.17
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 4.17
Human Treg IL-12 stimulation 4.14
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 4.12
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.08
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.06
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.06
High-throughput sequencing of pluripotent cells 4.05
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.01
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.01
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.0
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.99
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.99
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.94
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.94
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 3.91
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.89
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.88
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.85
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 3.84
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.83
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.8
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.79
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.78
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.77
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.77
H1609088 Human RNA-Sequencing 3.76
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.76
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.71
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 3.71
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.69
Identification of HOXB13 target genes responsive to BET inhibitors 3.67
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 3.67
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.65
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 3.65
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.62
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 3.6
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 3.6
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.6
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.55
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.54
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.54
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 3.53
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 3.53
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.48
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.42
K562 polyA RNA-Seq 3.41
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.34
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 3.31
Transcriptional responses of melanoma cells to BRAF inhibition 3.31
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.28
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.28
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.26
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.25
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.25
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 3.24
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.24
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.23
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.22
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.19
Ribosome profiling upon inhibition of eIF4A 3.19
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.15
RNA-seq analysis upon ARID1B overexpression 3.13
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.12
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.12
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.06
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 3.05
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.03
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 3.01
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.0
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.97
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.97
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.94
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.94
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.94
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.91
miRNAs affected by antagomiR-17 treatment 2.9
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.9
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.85
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.82
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.79
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.77
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 2.76
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 2.76
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 2.76
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.75
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.74
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.7
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.69
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.68
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.68
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.65
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.64
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.62
Functional significance of the HIV-1 Tat signature amino acid residues 2.59
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.59
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.58
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.54
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.52
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.52
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.5
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.49
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.49
Peptidomimetic blockade of MYB in acute myeloid leukemia 2.49
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 2.49
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.4
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.38
Effect of CHKA knockdown on C4-2 cell transcriptome 2.37
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.34
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.33
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.33
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.33
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.32
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.32
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.27
Role of FGFR1 in neuronal devlopment 2.26
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.25
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.24
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.22
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.21
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.17
Genetic-to-epigenetic Therapy for Pancreatic Cancer 2.15
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.1
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.1
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.09
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.04
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.03
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.01
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.01
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.99
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.99
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.99
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.96
Identification of a LIF-responsive replication-competent human β cell 1.95
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.94
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.94
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.92
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.92
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.88
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.88
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.83
RNA sequencing of human mammary epithelial cells 1.81
O-glcnAc reprograms cellular energetics 1.8
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.75
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.73
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.73
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.66
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.62
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.58
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.52
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.5
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.48
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.48
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.45
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.44
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.42
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.41
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.4
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.37
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.37
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.37
Single-cell analysis of adult human ovary using 10X genomics 1.36
Transcriptional landscape changes during human embryonic stem cell derivation 1.35
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.34
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.34
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.34
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.28
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.27
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.23
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.23
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.23
Effect of PRDM11 depletion in U2932 cells 1.22
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.2
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.18
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.18
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.18
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.12
Transcriptomic analysis of LSD1 1.12
ML29755 RNA-seq data 1.09
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.08
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.08
High-resolution comparative analysis of great ape genomes 1.04
RNA seq analysis of human Fetal and adult derived Enterospheres 1.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.03
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.02
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.02
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.99
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.98
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.98
Gene expression changes due to PARP knockdown in human cells 0.97
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.97
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.93
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.91
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.9
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.9
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.88
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.87
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.86
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.86
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.85
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.85
Electronic cigarettes 0.85
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.82
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.81
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.8
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.8
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.78
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.78
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.76
RNA seq with AML (NB4) cells upon FTO inhibition 0.76
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.73
SNHG5 siRNA knock down in HCT116 cells 0.65
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.64
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.63
HBEC-shp53-PCHD7 0.62
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.56
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.54
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.54
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.5
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.44
Global transcriptome analysis of WT versus HEB-/- hESCs 0.4
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.39
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.38
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.37
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.35
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.35
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 0.34
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.31
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.3
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.3
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.3
Role of cervicovaginal microbiota in genital inflammation 0.29
siRNA-mediated knockdown 0.27
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.25
Genome-wide analysis of the Integrator complex (HTS) 0.25
Genome-wide analysis of the Integrator complex 0.25
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.23
HNRNPM-regulated splicing dependencies in prostate cancer 0.23
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.15
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.15
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.11
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.11
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.08
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.07
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.05
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.04
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.04
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.03
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.01
Transcriptome analysis of SKI knock-out in HL60 cells 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
miR-93 Targets in Human Endothelial Cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation